Viewing Study NCT00895466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2026-05-21 @ 11:56 AM
Study NCT ID: NCT00895466
Status: UNKNOWN
Last Update Posted: 2009-05-08
First Post: 2009-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Sponsor: Pepscan Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostatic diseases View
None neoplasms View
None prostatic neoplasms View
None hormones View
None androgen antagonists View
None vaccines View
None peptide vaccines View
None adjuvants, immunological View